News

Keya medical's plaque analysis and FFR-CT reports generated from a single CT scan.

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Pi-Cardia ShortCut TAVR device

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut? 

Roderick Tung explains cardio-neuro ablation therapy for recurrent vasovagal syncope

The procedure is designed to help patients who experience frequent fainting episodes that impair their quality of life.

Medicare Advantage

"These high costs could pose barriers to care for such plans’ beneficiaries,” researchers wrote July 1 in the American Journal of Roentgenology

cybersecurity cyberattack hack hackers lock protection

The feds cautioned that exploitation of these vulnerabilities could allow attackers to write files, access unauthorized information, or crash client servers. 

Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU

The Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU seeks to develop new treatments that could help the millions of individuals impacted by these ailments. 

surgeon

With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in? 

Physician warning

Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.

Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, spoke with Cardiovascular Business at the Heart Rhythm 2026 meeting in the above video interview. She explained both the explosion of PFA use since the first FDA approvals in 2024, and the recently discovered complications of coronary vessel spasm and hemolysis and how newer PFA technology might address this.

Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.

Thumbnail

“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11. 

UnitedHealthcare UHC UnitedHealth

Meanwhile, the Maryland State Medical Society is formally urging the administration to reject the mid-year request, contending it will harm patients and providers. 

Around the web

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?